Shares of International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.08 and traded as high as $0.11. International Stem Cell shares last traded at $0.11, with a volume of 12,000 shares changing hands.
International Stem Cell Trading Down 8.4 %
The firm has a 50 day moving average price of $0.09 and a 200-day moving average price of $0.08. The firm has a market cap of $909,600.00, a PE ratio of -1.42 and a beta of 0.17.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Featured Stories
- Five stocks we like better than International Stem Cell
- What is a support level?
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- Trading Halts Explained
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
- Top Stocks Investing in 5G Technology
- 3 Stocks With Rising Prices That Are Likely to Split in 2025
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
